Inmune Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.17

+0.09 (+4.33%)

As of Aug 15, 2:25 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +677.4% upside

Low Target $11.09

Average Target $16.87

High Target $25.84

Current Price $2.17

Current
$2.17

Target
$16.87

$11.09 $16.87 avg $25.84

Scenario Analysis

Bear Case

$11.09

411.1%

Low target

Base Case

$16.87

+677.4%

Avg target

Bull Case

$25.84

+1,090.8%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$2.61

-16.8% from high

52-Week Low

$1.09

+99.1% from low

Target vs 52W High

$16.87

+546.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%